Infex candidate nominated for COV-X programme
Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response
Read More
Tag: candidate
Positive efficacy data for Sensorian’s candidate
SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation
Read More
Alchemab Therapeutics reveals Alzheimer’s candidate
ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein
Read More
Positive profile for Enterome’s lymphoma candidate
EO2463 is an experimental treatment for indolent non-Hodgkin B cell lymphoma
Read More
Positive data for Acesion’s atrial fibrillation candidates
The company intends to advance AF drugs that address current risk concerns with existing therapies
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
